Enzyme Replacement Therapy Market – Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Image Credit : https://www.medgadget.com/

Enzyme replacement therapy involves intravenous administration of enzymes in order to correct the deficiency of enzymes that causes a specific disease condition called lysosomal storage disease. Enzyme replacement therapy is used in Fabry Disease, Gaucher disease, lysosomal acid lipase deficiency, mucopolysaccharidosis, Hunter syndrome, and Pompe disease. Enzymes are obtained from sources such as human cells, animal cells, and recombinant DNA technology. Enzyme replacement, although does not provide permanent cure, helps prevents permanent damage to the body caused due to deficiency of a specific enzyme.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1752

Treatment consists of weekly or monthly doses depending upon the disease. For instance, in order to address enzyme deficiency in Gaucher disease, modified version of glucocerebrosidase is administered intravenously every two weeks. Enzyme replacement is associated with fewer side effects than other treatment methods. However, enzyme replacement therapy may be inconvenient for some patients such as children and geriatric population due to intravenous administration. It may result in local infusion reaction or hypersensitive reactions in the form of local rash, fever, edema, bronchospasm or hypotension.

Increasing collaborations amongst key companies to fast-track the development of enzymes for replacement is expected to boost growth of the enzyme replacement therapy market size. For instance, in March 2018, Shire plc entered into a preclinical research collaboration with NanoMedSyn— French biotech company—to develop enzyme replacement treatment for a lysosomal storage disorder based on NanoMedSyn’s synthetic derivative technology named AMFA.

Click To Continue Reading on Enzyme replacement therapy Market

However, high cost associated with the enzyme replacement therapy and complex reimbursement scenario causing therapy to be excluded from coverage by insurers due to this being a rare disease, hamper growth of the enzyme replacement therapy market.

You may be interested

Cladding Systems Market Shows Expected Trend to Guide from 2018-2026 with Growth Analysis
Business
Business

Cladding Systems Market Shows Expected Trend to Guide from 2018-2026 with Growth Analysis

Mohit Joshi - August 20, 2018

Cladding Systems Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share,…

Guar Gum Market Applications, Types and Market Analysis to 2026
Chemicals and Polymer Science
Chemicals and Polymer Science

Guar Gum Market Applications, Types and Market Analysis to 2026

Alex Mathew - August 20, 2018

Guar Gum Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share,…

Blister Packaging Market Trends Estimates High Demand by 2026
Business
Business

Blister Packaging Market Trends Estimates High Demand by 2026

Mohit Joshi - August 20, 2018

Blister Packaging Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share,…

Most from this category